DMEMEDS shared post via Reuters: Bayer says Nexavar fails in breast cancer study

FRANKFURT (Reuters) - German drugmaker Bayer said a Phase III trial of cancer drug Nexavar in patients with advanced breast cancer did not meet its primary endpoint of delaying the progression of the disease. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/2cp2wxN6nGs/story01.htm

Read More